Calidi Biotherapeutics Stock Buy Hold or Sell Recommendation
| CLDI Stock | 1.24 0.05 3.88% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Calidi Biotherapeutics is 'Strong Sell'. The recommendation algorithm takes into account all of Calidi Biotherapeutics' available fundamental, technical, and predictive indicators you will find on this site. Check out Calidi Biotherapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Calidi Stock please use our How to Invest in Calidi Biotherapeutics guide. In addition, we conduct extensive research on individual companies such as Calidi and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Calidi Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
Execute Calidi Biotherapeutics Buy or Sell Advice
The Calidi recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Calidi Biotherapeutics. Macroaxis does not own or have any residual interests in Calidi Biotherapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Calidi Biotherapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weakest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Risky | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Calidi Biotherapeutics Trading Alerts and Improvement Suggestions
| Calidi Biotherapeutics generated a negative expected return over the last 90 days | |
| Calidi Biotherapeutics may become a speculative penny stock | |
| Calidi Biotherapeutics has high historical volatility and very poor performance | |
| Calidi Biotherapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (22.21 M) with profit before overhead, payroll, taxes, and interest of 31 K. | |
| Calidi Biotherapeutics generates negative cash flow from operations | |
| About 15.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 850 shares by Allan Camaisa of Calidi Biotherapeutics at 1.455 subject to Rule 16b-3 |
Calidi Biotherapeutics Returns Distribution Density
The distribution of Calidi Biotherapeutics' historical returns is an attempt to chart the uncertainty of Calidi Biotherapeutics' future price movements. The chart of the probability distribution of Calidi Biotherapeutics daily returns describes the distribution of returns around its average expected value. We use Calidi Biotherapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Calidi Biotherapeutics returns is essential to provide solid investment advice for Calidi Biotherapeutics.
| Mean Return | -0.25 | Value At Risk | -6.45 | Potential Upside | 6.04 | Standard Deviation | 4.19 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Calidi Biotherapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Calidi Biotherapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Calidi Biotherapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Calidi Biotherapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Calidi stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.36 | |
β | Beta against Dow Jones | 1.28 | |
σ | Overall volatility | 4.07 | |
Ir | Information ratio | -0.08 |
Calidi Biotherapeutics Volatility Alert
Calidi Biotherapeutics exhibits very low volatility with skewness of -0.11 and kurtosis of 1.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Calidi Biotherapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Calidi Biotherapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Calidi Biotherapeutics Fundamentals Vs Peers
Comparing Calidi Biotherapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Calidi Biotherapeutics' direct or indirect competition across all of the common fundamentals between Calidi Biotherapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Calidi Biotherapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Calidi Biotherapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Calidi Biotherapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Calidi Biotherapeutics to competition |
| Fundamentals | Calidi Biotherapeutics | Peer Average |
| Return On Asset | -1.2 | -0.14 |
| Current Valuation | 1.82 M | 16.62 B |
| Shares Outstanding | 7.17 M | 571.82 M |
| Shares Owned By Insiders | 15.44 % | 10.09 % |
| Shares Owned By Institutions | 3.26 % | 39.21 % |
| Number Of Shares Shorted | 71.33 K | 4.71 M |
| Price To Book | 1.28 X | 9.51 X |
| Price To Sales | 50.83 X | 11.42 X |
| Gross Profit | 31 K | 27.38 B |
| EBITDA | (19.73 M) | 3.9 B |
| Net Income | (22.21 M) | 570.98 M |
| Total Debt | 7.04 M | 5.32 B |
| Book Value Per Share | 0.98 X | 1.93 K |
| Cash Flow From Operations | (19.69 M) | 971.22 M |
| Short Ratio | 0.87 X | 4.00 X |
| Earnings Per Share | 0.36 X | 3.12 X |
| Target Price | 120.0 | |
| Number Of Employees | 28 | 18.84 K |
| Beta | 1.08 | -0.15 |
| Market Capitalization | 8.89 M | 19.03 B |
| Total Asset | 14.18 M | 29.47 B |
| Retained Earnings | (121.72 M) | 9.33 B |
| Working Capital | 731 K | 1.48 B |
| Net Asset | 14.18 M |
Note: Disposition of 850 shares by Allan Camaisa of Calidi Biotherapeutics at 1.455 subject to Rule 16b-3 [view details]
Calidi Biotherapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Calidi . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Calidi Biotherapeutics Buy or Sell Advice
When is the right time to buy or sell Calidi Biotherapeutics? Buying financial instruments such as Calidi Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Calidi Biotherapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long Short Funds Thematic Idea Now
Long Short Funds
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Calidi Biotherapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Calidi Stock please use our How to Invest in Calidi Biotherapeutics guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Calidi Biotherapeutics. If investors know Calidi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Calidi Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Calidi Biotherapeutics is measured differently than its book value, which is the value of Calidi that is recorded on the company's balance sheet. Investors also form their own opinion of Calidi Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Calidi Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Calidi Biotherapeutics' market value can be influenced by many factors that don't directly affect Calidi Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Calidi Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Calidi Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Calidi Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.